Inhibition of VEGFR2 does not affect the overexpression of KLF2 or KLF4 after CCM2 loss [42], but it can partially prevent the development of cavernomas in CCM1-deficient animals [24]. This evidence concerns the gene CCM2 and cavernous hemangioma.